Biotech & Life Science Fund A/S

CVR 42582557 · Public limited company (A/S) · Active · Low risk

Biotech & Life Science Fund A/S is a Public limited company (A/S), founded on , based in Holte. The company is registered in the industry investering for egen regning. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 7.8m and a net result of DKK 647k.

Bankruptcy risk for Biotech & Life Science Fund A/S

0.1%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 27% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Company typeA/S · bankruptcy rate 4.4%0.50×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42582557
Status
Active
Company type
Public limited company (A/S)
Founded
(5 years)
Address
c/o Sorgenfri Kapitalforvaltning A/S, Kongevejen 365
2840 Holte
Municipality
Rudersdal
Industry
Investering for egen regning (649910)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 3.7m
Auditor
AIDER Godkendt Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 5
Missing annual reportNo
Negative equityNo
Equity ratio99.1%
Current ratio11,413%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address28
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -163kDKK -175k
Net profitDKK 647kDKK -609k
EquityDKK 7.8mDKK 8.4m
Total assetsDKK 7.9mDKK 8.5m
CashDKK 1.8m–
Short-term debtDKK 69k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Baker Tilly Denmark.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025120
1 Jan 2024 – 31 Dec 2024171
1 Jan 2023 – 31 Dec 202372
1 Jan 2022 – 31 Dec 2022114
3 Aug 2021 – 31 Dec 2021157

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
BoardKnud Erik AndreasenCurrent
BoardJesper Gerhard VogeliusCurrent
BoardStefan Poul RasmussenCurrent
Owner (5%)BJ HOLDING 98 A/SCurrent
Owner (20%)Kim Bengtsson
Owner (5%)Niels Frich
Owner (15%)Peter Ulrik Rasmussen
Owner (15%)Ida Laug
Owner (5%)Helene Stonor Krum-Møller
Owner (5%)Black Rasmussen Holding ApS
Owner (10%)C.U.P. Management Aps
Owner (5%)STAVNSKÆR HOLDING ApS
Owner (5%)KHH INVEST ApS
AuditorAIDER Godkendt RevisionsaktieselskabCurrent
FounderStefan Poul RasmussenCurrent

Address history (1 moves)

c/o Sorgenfri Kapitalforvaltning A/S, Kongevejen 365, 2840 Holte
c/o Sorgenfri Kapitalforvaltning A/S, Kongevejen 365, 2840 Holte

Other companies at the same address

Similar companies in Rudersdal

Questions and answers about Biotech & Life Science Fund A/S

Has Biotech & Life Science Fund A/S gone bankrupt?

No, Biotech & Life Science Fund A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Biotech & Life Science Fund A/S?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the auditor of Biotech & Life Science Fund A/S?

Biotech & Life Science Fund A/S most recently used AIDER Godkendt Revisionsaktieselskab.

When was Biotech & Life Science Fund A/S founded?

Biotech & Life Science Fund A/S was founded on 3 August 2021.

What is the equity of Biotech & Life Science Fund A/S?

Equity was DKK 7.8m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.